• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从三种吸入器设备中解聚粘性粉末的动力学。

The kinetics of cohesive powder de-agglomeration from three inhaler devices.

机构信息

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.

出版信息

Int J Pharm. 2011 Dec 12;421(1):72-81. doi: 10.1016/j.ijpharm.2011.09.024. Epub 2011 Sep 21.

DOI:10.1016/j.ijpharm.2011.09.024
PMID:21963469
Abstract

PURPOSE

The purpose of the current investigation is to understand the kinetics of de-agglomeration (k(d)) of micronised salbutamol sulphate (SS) and lactohale 300 (LH300) under varying air flow rates (30-180l min(-1)) from three dry powder inhaler devices (DPIs), Rotahaler (RH), Monodose Inhaler (MI) and Handihaler (HH).

RESULTS

Cumulative fine particle mass vs. time profiles were obtained from the powder concentration, emitted mass and volume percent <5.4 μm, embedded in the particle size distributions of the aerosol at specific times. The rate of de-agglomeration (k(d)), estimated from non-linear least squares modelling, increased with increasing air flow rates. The k(d)vs. air flow rate profiles of SS and LH300 were significantly different at high air flow rates. The k(d) was highest from RH and lowest from MI. Differences in k(d) between the devices were related to device mode of operation while the differences between the materials were due to the powder bed structure.

CONCLUSION

This approach provided a methodology to measure the rate constant for cohesive powder de-agglomeration following aerosolisation from commercial devices and an initial understanding of the influence of device, air flow rate and material on these rate constants.

摘要

目的

本研究旨在了解三种干粉吸入器(Rotahaler(RH)、单剂量吸入器(MI)和 Handihaler(HH))在不同空气流速(30-180l min(-1))下,微米化硫酸沙丁胺醇(SS)和乳糖海 300(LH300)的解团聚动力学(k(d))。

结果

从粉末浓度、发射质量和体积百分比<5.4μm 中获得了随时间变化的累积细颗粒质量与时间的关系曲线,这些数据嵌入在气溶胶的粒径分布中。通过非线性最小二乘法建模估算的解团聚速率(k(d))随着空气流速的增加而增加。在高空气流速下,SS 和 LH300 的 k(d)与空气流速曲线显著不同。RH 的 k(d)最高,MI 的 k(d)最低。设备之间的 k(d)差异与设备的操作模式有关,而材料之间的差异则归因于粉末床结构。

结论

该方法提供了一种测量从商业设备气溶胶化后粘性粉末解团聚速率常数的方法,并初步了解了设备、空气流速和材料对这些速率常数的影响。

相似文献

1
The kinetics of cohesive powder de-agglomeration from three inhaler devices.从三种吸入器设备中解聚粘性粉末的动力学。
Int J Pharm. 2011 Dec 12;421(1):72-81. doi: 10.1016/j.ijpharm.2011.09.024. Epub 2011 Sep 21.
2
Insight into pressure drop dependent efficiencies of dry powder inhalers.干粉吸入器压降相关效率的深入了解。
Eur J Pharm Sci. 2012 Jun 14;46(3):142-8. doi: 10.1016/j.ejps.2012.02.019.
3
Structural influence of cohesive mixtures of salbutamol sulphate and lactose on aerosolisation and de-agglomeration behaviour under dynamic conditions.硫酸沙丁胺醇和乳糖的粘性混合物对动态条件下气溶胶化和去团聚行为的结构影响。
Eur J Pharm Sci. 2011 Feb 14;42(3):210-9. doi: 10.1016/j.ejps.2010.11.008. Epub 2010 Nov 26.
4
Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.了解粉末流动性、流化和团聚体破碎特性对药物模型粉末气溶胶化的影响。
Eur J Pharm Sci. 2010 Aug 11;40(5):412-21. doi: 10.1016/j.ejps.2010.04.012. Epub 2010 Apr 28.
5
Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.湿度引起的含有不同载体的干粉气雾剂制剂空气动力学性质的变化。
Int J Pharm. 2007 Mar 21;333(1-2):45-55. doi: 10.1016/j.ijpharm.2006.09.048. Epub 2006 Oct 1.
6
Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.用于测定雾化粉末制剂粒度的激光衍射方法的开发。
Int J Pharm. 2006 Dec 1;326(1-2):39-49. doi: 10.1016/j.ijpharm.2006.07.021. Epub 2006 Jul 16.
7
Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.干粉吸入剂中的空气分级器技术(ACT) 第4部分。Novolizer多剂量干粉吸入器中空气分级器技术的性能。
Int J Pharm. 2006 Mar 9;310(1-2):81-9. doi: 10.1016/j.ijpharm.2005.11.029. Epub 2006 Jan 25.
8
Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.丙酸氟替卡松在干粉吸入剂制剂中的聚集行为。
Eur J Pharm Biopharm. 2012 Apr;80(3):596-603. doi: 10.1016/j.ejpb.2011.12.004. Epub 2011 Dec 14.
9
An insight into powder entrainment and drug delivery mechanisms from a modified Rotahaler®.对改良型都保®粉雾夹带及药物递送机制的洞察。
Int J Pharm. 2014 Dec 30;477(1-2):351-60. doi: 10.1016/j.ijpharm.2014.08.038. Epub 2014 Sep 6.
10
The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.结晶乳糖的物理性质和形态对硫酸沙丁胺醇干粉吸入剂释药的影响。
Colloids Surf B Biointerfaces. 2012 Jan 1;89:29-39. doi: 10.1016/j.colsurfb.2011.08.019. Epub 2011 Sep 10.

引用本文的文献

1
A Quality by Design Framework for Capsule-Based Dry Powder Inhalers.基于胶囊的干粉吸入器的质量源于设计框架
Pharmaceutics. 2021 Aug 6;13(8):1213. doi: 10.3390/pharmaceutics13081213.
2
Advances in device and formulation technologies for pulmonary drug delivery.肺部药物递送的装置与制剂技术进展
AAPS PharmSciTech. 2014 Aug;15(4):882-97. doi: 10.1208/s12249-014-0114-y. Epub 2014 Apr 12.
3
Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications.高效干粉吸入器的研发:胶囊腔室设计及吸入器表面改性的影响
Pharm Res. 2014 Feb;31(2):360-72. doi: 10.1007/s11095-013-1165-6. Epub 2013 Aug 16.